Barinthus Biotherapeutics (BRNS) Selling, General & Administrative (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Selling, General & Administrative of $7.1 million for Q2 2026, down 53.8% from $15.38 million a year earlier but up 180.9% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Barinthus Biotherapeutics' Selling, General & Administrative came in at $22.44 million, down 49.6% year-over-year; for FY2025, it came in at $40.83 million, up 37.6% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 31.3% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $29.67 million in FY2024 (-25.5%), $39.84 million in FY2023 (+523.1%), $6.39 million in FY2022 (-74.5%) and $25.12 million in FY2021 (+139.7%).
- Five-year quarterly Selling, General & Administrative spans a low of $961,000 in Q3 2023 and a high of $15.38 million in Q2 2025.
- Year over year, Selling, General & Administrative gained in three of the last seven quarters, with growth averaging 14.5%.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2023 (growth of 231.4%); the low point was Q1 2026 (a decline of 80.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.53 million (Q1 2026), $7.64 million (Q4 2025) and $5.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - | 7.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.10 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 7.64 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 15.38 Mn |
| Mar 31, 2025 | 12.64 Mn |
| Dec 31, 2024 | 3.06 Mn |
| Sep 30, 2024 | 13.42 Mn |
| Jun 30, 2024 | 7.20 Mn |
| Mar 31, 2024 | 5.99 Mn |
| Dec 31, 2023 | 13.62 Mn |
| Sep 30, 2023 | 961,000.00 |
| Jun 30, 2023 | 13.13 Mn |
| Mar 31, 2023 | 12.14 Mn |
| Mar 31, 2022 | 3.66 Mn |
| Dec 31, 2021 | 9.79 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 12.37 Mn |
| Mar 31, 2021 | 1.78 Mn |
| Dec 31, 2020 | 7.42 Mn |
API Access
Barinthus Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();